Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

  1. Stolz, D.
  2. Hermansson, E.
  3. Ouwens, M.
  4. Singh, B.
  5. Sharma, A.
  6. Jackson, D.
  7. Darken, P.
  8. Marshall, J.
  9. Bowen, K.
  10. Müllerová, H.
  11. Alcázar Navarrete, B.
  12. Russell, R.
  13. Han, M.K.
  14. Tansey-Dwyer, D.
Revista:
Current Medical Research and Opinion

ISSN: 1473-4877,  0300-7995

Any de publicació: 2023

Volum: 39

Número: 10

Pàgines: 1395-1405

Tipus: Article

DOI: 10.1080/03007995.2023.2247969 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus